A recent survey of ABO blood group distribution of 80,982,137 normal people from Iran was used as comparison controls for patients with COVID-19 (https://en.wikipedia.org/wiki/Blood_type_distribution_by_country). This evidence concerns the gene ABO and COVID-19.